CVX vs TMO: Which Is the Better Buy?
Side-by-side comparison of Chevron Corporation and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Chevron Corporation · Energy
$193.33
-13.1% upside to fair value
Grade D
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
TMO has more upside to fair value
(+10.1%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CVX |
TMO |
| Current Price |
$193.33 |
$462.60 |
| Fair Value Estimate |
$168.03 |
$509.20 |
| Upside to Fair Value |
-13.1%
|
+10.1%
|
| Market Cap |
$385.8B |
$171.9B |
| Forward P/E |
31.3x
|
25.1x
|
| EV / EBITDA |
10.3x
|
19.0x
|
| Price / Sales |
2.1x
|
3.8x
|
| Price / FCF |
23.8x
|
25.5x
|
| Revenue Growth YoY |
-5.3%
|
+6.2%
|
| Gross Margin |
30.4%
|
39.4%
|
| Operating Margin |
9.0%
|
17.8%
|
| Return on Equity |
7.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.19%
|
3.92%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Chevron Corporation operates as a leading integrated oil and gas company with significant upstream and downstream operations. The company benefits from experienced leadership under CEO Mike Wirth, who has over 44 years with Chevron, and maintains a strong market position as the second largest Big Oil major by market cap and net profits. However, Chevron currently trades at a very expensive valuat…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
CVX |
TMO |
| Zone Low |
$126.02 |
$381.90 |
| Zone High |
$142.83 |
$432.82 |
| In Buy Zone? |
No
|
No
|